Furthermore, both CD5- and CD19-NSCAR (non-signaling CARs) modified γδ T cells demonstrated a significant increase in killing T-ALL and B-ALL cell lines, respectively [237]. The gene discussed is CD5; the disease is acute lymphoblastic leukemia.